Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$1.46 - $2.48 $31,788 - $53,997
-21,773 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$1.84 - $2.83 $13,110 - $20,163
7,125 Added 48.64%
21,773 $54,000
Q2 2020

Aug 14, 2020

BUY
$2.1 - $4.6 $30,760 - $67,380
14,648 New
14,648 $52,000

Others Institutions Holding NYMX

About NYMOX PHARMACEUTICAL CORP


  • Ticker NYMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,265,000
  • Market Cap $42.9M
  • Description
  • Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...
More about NYMX
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.